Verastem, Inc. Files 8-K Report

Ticker: VSTM · Form: 8-K · Filed: Apr 9, 2024 · CIK: 1526119

Verastem, INC. 8-K Filing Summary
FieldDetail
CompanyVerastem, INC. (VSTM)
Form Type8-K
Filed DateApr 9, 2024
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k

TL;DR

Verastem filed an 8-K, likely containing important company updates.

AI Summary

On April 9, 2024, Verastem, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates Verastem, Inc. is providing updates to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific financial or operational details that would indicate high risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What is Verastem, Inc.'s principal executive office address?

Verastem, Inc.'s principal executive offices are located at 117 Kendrick Street, Suite 500, Needham, MA 02494.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on April 9, 2024.

What is Verastem, Inc.'s telephone number?

Verastem, Inc.'s telephone number, including area code, is (781) 292-4200.

What is Verastem, Inc.'s state of incorporation?

Verastem, Inc. is incorporated in Delaware.

Filing Stats: 410 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2024-04-09 17:10:30

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure On April 9, 2024, Verastem, Inc. posted its corporate presentation on its website, a copy of which is furnished hereto as Exhibit 99.1 to this Current Report on Form 8-K. Item 9.01. Financial Statements and Exhibits Exhibit No. Description 99.1 Corporate Presentation, dated April 9, 2024 104 Cover Page Interactive Data File (formatted in Inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VERASTEM, INC. Dated: April 9, 2024 By: /s/ Da niel W. Paterson Daniel W. Paterson President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing